| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 20 |
| 1 | OXALIPLATIN | 19 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 13 |
| 3 | ADALIMUMAB | 12 |
| 4 | ATEZOLIZUMAB | 12 |
| 5 | ESOMEPRAZOLE | 12 |
| 6 | CAPECITABINE | 11 |
| 7 | HYDROMORPHONE HYDROCHLORIDE | 11 |
| 8 | ADALIMUMAB-AATY | 8 |
| 9 | ADALIMUMAB-ADAZ | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 1 | ANIDULAFUNGIN | 1 | 0.0006 |
| 2 | DOSTARLIMAB | 1 | 0.0004 |
| 3 | ATEZOLIZUMAB | 12 | 0.0003 |
| 4 | FRUQUINTINIB | 1 | 0.0003 |
| 5 | OXALIPLATIN | 19 | 0.0003 |
| 6 | POLATUZUMAB VEDOTIN | 2 | 0.0002 |
| 7 | RIPRETINIB | 1 | 0.0002 |
| 8 | ADALIMUMAB-FKJP | 8 | 0.0002 |
| 9 | REGORAFENIB | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 17 | 0.0002 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 2 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 20 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 27 | 0.0001 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 18 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |
| 9 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |